News

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the April 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the July 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the December 2027 expiration. One of the key inputs that goes into the price an option buyer is ...
July 17, 2025 — 08:21 am EDT Written by Quiver ForecastTracker for Quiver Quantitative -> ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the December 15th expiration. One of the key data points that goes into the price an option buyer ...
Fintel reports that on May 14, 2024, Oppenheimer upgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from Perform to Outperform. Analyst Price Forecast Suggests 29.21% Upside As of May ...
Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the March 2023 expiration. One of the key data points that goes into the price an option buyer is ...
Whales with a lot of money to spend have taken a noticeably bullish stance on Sarepta Therapeutics.Looking at options history for Sarepta Therapeutics (NASDAQ:SRPT) we detected 13 trades.If we ...
Shares of Sarepta Therapeutics SRPT nosedived 35.9% on Friday following the death of a patient dosed with one of its experimental gene therapies. The company confirmed that a 51-year-old, non ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock climbed by 5.3% resulting in a US$375m addition to the ...
Particularly high volume was seen for the $100 strike call option expiring January 15, 2021, with 6,226 contracts trading so far today, representing approximately 622,600 underlying shares of SRPT.